Seroprevalence of IgM and IgG Against SARS-CoV-2 after Two Doses of Pfizer-BioNTech COVID-19 Vaccine in Women with Breast Cancer.

Almehmadi, Mazen; Salih, Magdi M; Shafie, Alaa; Alsharif, Abdulaziz; Alsiwiehr, Naif; El-Askary, Ahmad; Alzahrani, Khalid; Al-Hazmi, Ayman; Aljuaid, Abdulelah; Abdulazziz, Osama; Almalki, Abdulraheem A; Allahyani, Mamdouh; Eed, Emad; Alharbi, Ahmad M; Halawi, Mustafa; Allam, Hatem H; Abutawil, Hisham; Alosimi, Ebtisam; Gharib, Amal F

Almehmadi, Mazen; Salih, Magdi M; Shafie, Alaa; Alsharif, Abdulaziz; Alsiwiehr, Naif; El-Askary, Ahmad; Alzahrani, Khalid; Al-Hazmi, Ayman; Aljuaid, Abdulelah; Abdulazziz, Osama; Almalki, Abdulraheem A; Allahyani, Mamdouh; Eed, Emad; Alharbi, Ahmad M; Halawi, Mustafa; Allam, Hatem H; Abutawil, Hisham; Alosimi, Ebtisam; Gharib, Amal F.

Clin Lab ; 68(11)2022 Nov 01.

Article em En | MEDLINE | ID: mdl-36378000

Assuntos

Neoplasias da Mama; COVID-19; Carcinoma Ductal; Humanos; Feminino; Pessoa de Meia-Idade; SARS-CoV-2; Imunoglobulina M; Estudos Soroepidemiológicos; COVID-19/epidemiologia; COVID-19/prevenção & controle; Vacina BNT162; Vacinas contra COVID-19; Anticorpos Antivirais; Imunoglobulina G

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Ductal / COVID-19 Limite: Female / Humans / Middle aged Idioma: En Revista: Clin Lab Assunto da revista: TECNICAS E PROCEDIMENTOS DE LABORATORIO Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google